U.S. markets close in 50 minutes

  • S&P 500

    3,770.91
    -47.92 (-1.25%)
     

  • Dow 30

    30,651.49
    -377.82 (-1.22%)
     

  • Nasdaq

    10,989.05
    -188.84 (-1.69%)
     

  • Russell 2000

    1,704.37
    -15.00 (-0.87%)
     

  • Crude Oil

    105.70
    -4.08 (-3.72%)
     

  • Gold

    1,807.30
    -10.20 (-0.56%)
     

  • Silver

    20.27
    -0.46 (-2.23%)
     

  • EUR/USD

    1.0479
    +0.0035 (+0.34%)
     

  • 10-Yr Bond

    2.9830
    -0.1100 (-3.56%)
     

  • GBP/USD

    1.2176
    +0.0053 (+0.44%)
     

  • USD/JPY

    135.5760
    -0.9690 (-0.71%)
     

  • BTC-USD

    18,963.10
    -1,091.35 (-5.44%)
     

  • CMC Crypto 200

    407.00
    -24.47 (-5.67%)
     

  • FTSE 100

    7,169.28
    -143.04 (-1.96%)
     

  • Nikkei 225

    26,393.04
    -411.56 (-1.54%)
     

IPO Outlook For The Week: Banks And Biotechs

Elizabeth Balboa

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed.

ADC Therapeutics SA (NYSE: ADCT) will issue nearly 8.2 million shares between $23 and $26 Thursday on the New York Stock Exchange. The offering represents 11.1% of outstanding shares and is expected to raise about $244.1 million. The clinical-stage biotech company develops therapies for solid tumors and hematological cancers.

Aprea Therapeutics, Inc. (NASDAQ: APRE) will issue 5 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 26% of outstanding shares and is expected to raise about $92 million. With operations in Boston and Sweden, the biopharmaceutical company develops protein therapies for acute myeloid leukemia, myelodysplastic syndromes and other oncological indications.

Frequency Therapeutics, Inc. (NASDAQ: FREQ) will issue 6.7 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 21.5% of outstanding shares and is expected to raise about $123.3 million. The clinical-stage company produces therapies for degenerative diseases like multiple sclerosis and sensorineural hearing loss.

Metrocity Bankshares, Inc. will issue more than 1.9 million shares between $14.50 and $16.50 Thursday on the Nasdaq. The offering represents 7.7% of outstanding shares and is expected to raise about $36.8 million. Headquartered in Georgia, the financial services company supports personal and business banking through 10 locations in Georgia, Alabama and Florida.

Viela Bio, Inc. (NASDAQ: VIE) will issue 7.5 million shares between $19 and $21 Thursday on the Nasdaq. The offering represents 15.2% of outstanding shares and is expected to raise about $181.1 million. The Maryland biotech company develops therapies for autoimmune and inflammatory diseases.

Related Links:

What Is Reg A+?

What Is A Lock-Up Expiration Date And Why Is It Important?

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories